2020
|
Invention
|
Modified tff2 polypeptides. Described herein are modified TFF2 polypeptides, compositions compris... |
|
Invention
|
Method for treating neurocognitive dysfunction.
A method of treating corticosteroid-induced cogn... |
|
Invention
|
Anti-cd154 antibodies and uses thereof.
This disclosure relates to anti-human CD154 antibodies w... |
|
Invention
|
Anti-cd154 antibodies and uses thereof. This disclosure relates to anti-human CD154 antibodies wi... |
|
Invention
|
Methods and compositions for treating fatigue associated with disordered sleep using very low dos... |
|
Invention
|
Salt forms of s-(n, n-diethylcarbamoyl)glutathione.
The invention relates in various aspects to ... |
|
Invention
|
Salt forms of s-(n, n-diethylcarbamoyl)glutathione. The invention relates in various aspects to a... |
2019
|
Invention
|
Methods of treating acute stress disorder and posttraumatic stress disorder. This invention relat... |
|
Invention
|
Stem cells comprising synthetic chimeric vaccinia virus and methods of using them.
The invention... |
|
Invention
|
Synthetic chimeric vaccinia virus. The invention relates in various aspects to a synthetic chimer... |
|
Invention
|
Stem cells comprising synthetic chimeric vaccinia virus and methods of using them. The invention ... |
2018
|
Invention
|
Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodeg... |
|
Invention
|
Methods and compositions for treating symptoms associated with post-traumatic stress disorder usi... |
2017
|
Invention
|
Tianeptine oxalate salts and polymorphs. Disclosed herein is an oxalate salt/co-crystal (tianepti... |
2015
|
Invention
|
Eutectic formulations of cyclobenzaprine hydrochloride. The present invention relates to pharmace... |
|
Invention
|
Eutectic isometheptene mucate.
The present invention relates to pharmaceutical compositions and ... |
|
Invention
|
Eutectic isometheptene mucate. The present invention relates to pharmaceutical compositions and m... |
2014
|
Invention
|
Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride. The prese... |
2013
|
Invention
|
Compositions and methods for transmucosal absorption. The invention provides compositions and met... |
|
Invention
|
Compositions and methods for transmucosal absorption. The invention provides compositions, uses a... |
2012
|
Invention
|
Methods and compositions for treating depression using cyclobenzaprine. The present invention rel... |
2009
|
Invention
|
Method for treating neurocognitive dysfunction. A method of treating corticosteroid-induced cogni... |